Frontier Biotechnologies Inc. (SHA:688221)
China · Delayed Price · Currency is CNY 16.87
+0.45 (2.74%)
At close: Sep 30, 2026
Frontier Biotechnologies Market Cap
Frontier Biotechnologies has a market cap or net worth of 6.32 billion as of October 2, 2026. Its market cap has increased by 17.15% in one year.
Market Cap
6.32B
Enterprise Value
5.83B
Revenue
378.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.87
ChartMarket Cap Chart
Since October 28, 2020, Frontier Biotechnologies's market cap has decreased from 10.76B to 6.32B, a decrease of -41.27%. That is a compound annual growth rate of -8.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 6.32B | -6.54% |
| Dec 31, 2025 | 6.76B | 84.94% |
| Dec 31, 2024 | 3.66B | -1.61% |
| Dec 29, 2023 | 3.72B | -42.53% |
| Dec 30, 2022 | 6.47B | -3.33% |
| Dec 31, 2021 | 6.69B | -3.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Northeast Pharmaceutical Group | 6.69B |
| Hunan Er-Kang Pharmaceutical | 6.66B |
| Sunflower Pharmaceutical Group | 6.53B |
| Cisen Pharmaceutical | 6.44B |
| Bide Pharmatech | 6.40B |
| Guizhou Bailing Group Pharmaceutical | 6.32B |
| KPC Pharmaceuticals,Inc. | 6.06B |
| Chongqing Pharscin Pharmaceutical | 6.02B |